|
|
Article: Genetically engineered allergens fight allergic disease progression.
- Article from:
- Life Science Weekly
- Article date:
- December 14, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 DEC 14 - (NewsRx.com & NewsRx.net) -- Genetically engineered allergens fight allergic disease progression.
According to published research from Austria, "immunoglogulin E (IgE)-mediated allergy affects >25% of the population in industrialized countries. Repeated contact with the disease-eliciting allergens induces rises of allergen-specific IgE antibodies (Abs) and progression of the disease to more severe manifestations. Our study uses a type of vaccine that is based on genetically modified allergen derivatives to treat allergic patients."
"We developed hypoallergenic derivatives of the major birch pollen allergen, Bet v 1, by genetic engineering ...